Laserfiche WebLink
Page 6 <br />S.B. NO. X13 <br />1 (11) The use, on the labeling of any drug or in any <br />2 advertisement relating to the drug, of any <br />3 representation or suggestion that an application with <br />4 respect to the drug is effective under section 328 -17, <br />5 or that the drug complies with that section; <br />6 (12) The use by any person to the person's own advantage, <br />7 or revealing other than to the department of health or <br />8 to the courts when relevant in any judicial proceeding <br />9 under this part, any information acquired under <br />10 authority of section 328 -i1, 328 -12, 328 -17, or <br />11 328 -23, concerning any method or process which as a <br />12 trade secret is entitled to protection; <br />13 (13) In the case of a prescription drug distributed or <br />14 offered for sale in this State, the failure of the <br />15 manufacturer, packer, or distributor thereof to <br />16 maintain for transmittal, or to transmit, to any <br />17 practitioner who makes written request for information <br />18 as to the drug, true and correct copies of all printed <br />19 matter [which] that is required to be included in any <br />20 package in which that drug is distributed or sold, or <br />21 [sue] other printed matter as is approved under the <br />22 Federal Act. Nothing in this paragraph shall be <br />2011 -0122 SB SMA doc <br />I�I�I ll�� �II���I�G I��I�QIll�lDlll�lll� IC�I�I�fllll IO <br />